{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Kudinova AY"],"funding":["NICHD NIH HHS","National Institute on Alcohol Abuse and Alcoholism","American Psychological Association of Graduate Students","NCRR NIH HHS","NIMH NIH HHS","NIAAA NIH HHS","National Institute of Mental Health","National Institute of Child Health and Human Development","Department of Veteran Affairs","National Science Foundation"],"pagination":["482-94"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC4850099"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["125(4)"],"pubmed_abstract":["Extensive evidence highlights the role of inflammatory processes in major depressive disorder (MDD). However, most studies have examined a consistent set of inflammatory cytokines and there is evidence that other immune-derived products may play a role in MDD. In this article, we present data from 3 complimentary studies that support the role of a novel cytokine, interleukin-33 (IL-33), in depression risk. First, we show that a 2-SNP haplotype in the IL-33 gene (rs11792633 and rs7044343) moderated the link between women's history of childhood abuse and their history of recurrent MDD (rMDD), such that the link between childhood abuse and rMDD was stronger among women with fewer copies of the protective IL-33 CT haplotype. Second, linking these findings to differences in circulating cytokine"],"journal":["Journal of abnormal psychology"],"pubmed_title":["Cross-species evidence for the role of interleukin-33 in depression risk."],"pmcid":["PMC4850099"],"funding_grant_id":["S10 RR023457","0822129","K01 AA021113","HD057066","AA021113","R01 MH098060","MH098060","1S10RR023457-01A1","R01 HD057066"],"pubmed_authors":["Hueston CM","Kudinova AY","Gibb BE","Deak T","McGeary JE","Knopik VS","Palmer RH"],"additional_accession":[]},"is_claimable":false,"name":"Cross-species evidence for the role of interleukin-33 in depression risk.","description":"Extensive evidence highlights the role of inflammatory processes in major depressive disorder (MDD). However, most studies have examined a consistent set of inflammatory cytokines and there is evidence that other immune-derived products may play a role in MDD. In this article, we present data from 3 complimentary studies that support the role of a novel cytokine, interleukin-33 (IL-33), in depression risk. First, we show that a 2-SNP haplotype in the IL-33 gene (rs11792633 and rs7044343) moderated the link between women's history of childhood abuse and their history of recurrent MDD (rMDD), such that the link between childhood abuse and rMDD was stronger among women with fewer copies of the protective IL-33 CT haplotype. Second, linking these findings to differences in circulating cytokine","dates":{"release":"2016-01-01T00:00:00Z","publication":"2016 May","modification":"2026-05-30T11:23:16.353Z","creation":"2019-03-27T02:12:41Z"},"accession":"S-EPMC4850099","cross_references":{"pubmed":["27054346"],"doi":["10.1037/abn0000158"]}}